Highlights • Among outpatients in the United States who have heart failure with reduced ejection fraction, patients receiving target dosages of recommended medications generally have lower risks of dying and better outcomes. • Although some differences from the results of clinical trials were noted, this study, overall, suggests that benefits of target dosing apply to patients with heart failure receiving routine outpatient care in the United States.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Anne S.
Contact Anne S., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack